Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Pan-cancer interrogation of MUTYH variants reveals biallelic inactivation and defective base excision repair across a spectrum of solid tumors

Paller, Channing J., Tukachinsky, Hanna, Maertens, Alexandra, Decker, Brennan, Sampson, Julian R., Cheadle, Jeremy P. ORCID: https://orcid.org/0000-0001-9453-8458 and Antonarakis, Emmanuel S. 2024. Pan-cancer interrogation of MUTYH variants reveals biallelic inactivation and defective base excision repair across a spectrum of solid tumors. JCO Precision Oncology 8 (8) 10.1200/PO.23.00251

[thumbnail of paller-et-al-2024-pan-cancer-interrogation-of-mutyh-variants-reveals-biallelic-inactivation-and-defective-base-excision (1).pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB) | Preview

Abstract

Purpose Biallelic germline pathogenic variants of the base excision repair (BER) pathway gene MUTYH predispose to colorectal cancer (CRC) and other cancers. The possible association of heterozygous variants with broader cancer susceptibility remains uncertain. This study investigated the prevalence and consequences of pathogenic MUTYH variants and MUTYH loss of heterozygosity (LOH) in a large pan-cancer analysis. Materials and Methods Data from 354,366 solid tumor biopsies that were sequenced as part of routine clinical care were analyzed using a validated algorithm to distinguish germline from somatic MUTYH variants. Results Biallelic germline pathogenic MUTYH variants were identified in 119 tissue biopsies. Most were CRCs and showed increased tumor mutational burden (TMB) and a mutational signature consistent with defective BER (COSMIC Signature SBS18). Germline heterozygous pathogenic variants were identified in 5,991 biopsies and their prevalence was modestly elevated in some cancer types. About 12% of these cancers (738 samples: including adrenal gland cancers, pancreatic islet cell tumors, nonglioma CNS tumors, GI stromal tumors, and thyroid cancers) showed somatic LOH for MUTYH, higher rates of chromosome 1p loss (where MUTYH is located), elevated genomic LOH, and higher COSMIC SBS18 signature scores, consistent with BER deficiency. Conclusion This analysis of MUTYH alterations in a large set of solid cancers suggests that in addition to the established role of biallelic pathogenic MUTYH variants in cancer predisposition, a broader range of cancers may possibly arise in MUTYH heterozygotes via a mechanism involving somatic LOH at the MUTYH locus and defective BER. However, the effect is modest and requires confirmation in additional studies before being clinically actionable.

Item Type: Article
Date Type: Published Online
Status: Published
Schools: Medicine
Publisher: American Society of Clinical Oncology
ISSN: 2473-4284
Date of First Compliant Deposit: 27 February 2024
Date of Acceptance: 11 December 2023
Last Modified: 27 Feb 2024 10:53
URI: https://orca.cardiff.ac.uk/id/eprint/166568

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics